To further confirm the essential role of LAT1 in FGF21-mediated improvement in cardiac functions, AAV9-LAT1 was used for the specific overexpression of LAT1 in the heart of T1D mice during FGF21 treatment (Fig. 6a). This evidence concerns the gene SLC7A5 and type 1 diabetes mellitus.